Foresight Diagnostics to Present New Data on Foresight CLARITY™ MRD in Early-Stage Breast Cancer at ESMO Congress 2024
September 10, 2024 09:00 ET
|
Foresight Diagnostics, Inc.
BOULDER, Colo., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Foresight Diagnostics (Foresight), a leader in ultra-sensitive minimal residual disease (MRD) detection, today announced an upcoming presentation...
Foresight Diagnostics Expands Series B Financing to $73.75 Million to Advance the Foresight CLARITY™ MRD Platform
July 30, 2024 07:00 ET
|
Foresight Diagnostics, Inc.
BOULDER, Colo., July 30, 2024 (GLOBE NEWSWIRE) -- Foresight Diagnostics, Inc. (“Foresight”), a leading diagnostics company specializing in the development of ultra-sensitive minimal residual disease...